Icotrokinra seeks approval for psoriasis
#4
Update:

Quote:
Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy.

Source: jnj.com
Reply


Messages In This Thread
Icotrokinra seeks approval for psoriasis - by Fred - Tue-22-07-2025, 11:54 AM
RE: Icotrokinra seeks approval for psoriasis - by Fred - Fri-25-07-2025, 11:30 AM
RE: Icotrokinra seeks approval for psoriasis - by Fred - Wed-18-03-2026, 14:29 PM
RE: Icotrokinra seeks approval for psoriasis - by Fred - Thu-19-03-2026, 13:01 PM
RE: Icotrokinra seeks approval for psoriasis - by Fred - Fri-24-07-2026, 12:38 PM

Possibly Related Threads…
Thread Author Replies Views Last Post
  Pecondle gets China approval for psoriasis Fred 0 1,649 Fri-28-11-2025, 13:53 PM
Last Post: Fred
  Icotrokinra scalp and genital psoriasis results Fred 4 4,544 Tue-28-10-2025, 21:14 PM
Last Post: Fred
  Icotrokinra results for new psoriasis pill Fred 3 4,181 Thu-10-04-2025, 14:44 PM
Last Post: Fred
  FDA declines the approval of Duobrii for psoriasis Fred 1 5,229 Mon-27-05-2024, 21:06 PM
Last Post: Trampledrosie
  Tapinarof gets FDA approval for psoriasis Fred 6 10,203 Tue-31-01-2023, 18:41 PM
Last Post: Caroline



Users browsing this thread: 1 Guest(s)